Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease

The biochemical response to food intake must be precisely regulated. Because ingested sugars and fats can feed into many anabolic and catabolic pathways 1 , how our bodies handle nutrients depends on strategically positioned metabolic sensors that link the intrinsic nutritional value of a meal with...

Full description

Saved in:
Bibliographic Details
Published inNature (London) Vol. 566; no. 7742; pp. 115 - 119
Main Authors He, Shun, Kahles, Florian, Rattik, Sara, Nairz, Manfred, McAlpine, Cameron S., Anzai, Atsushi, Selgrade, Daniel, Fenn, Ashley M., Chan, Christopher T., Mindur, John E., Valet, Colin, Poller, Wolfram C., Halle, Lennard, Rotllan, Noemi, Iwamoto, Yoshiko, Wojtkiewicz, Gregory R., Weissleder, Ralph, Libby, Peter, Fernández-Hernando, Carlos, Drucker, Daniel J., Nahrendorf, Matthias, Swirski, Filip K.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.02.2019
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The biochemical response to food intake must be precisely regulated. Because ingested sugars and fats can feed into many anabolic and catabolic pathways 1 , how our bodies handle nutrients depends on strategically positioned metabolic sensors that link the intrinsic nutritional value of a meal with intermediary metabolism. Here we describe a subset of immune cells—integrin β7 + natural gut intraepithelial T lymphocytes (natural IELs)—that is dispersed throughout the enterocyte layer of the small intestine and that modulates systemic metabolism. Integrin β7 − mice that lack natural IELs are metabolically hyperactive and, when fed a high-fat and high-sugar diet, are resistant to obesity, hypercholesterolaemia, hypertension, diabetes and atherosclerosis. Furthermore, we show that protection from cardiovascular disease in the absence of natural IELs depends on the enteroendocrine-derived incretin GLP-1 2 , which is normally controlled by IELs through expression of the GLP-1 receptor. In this metabolic control system, IELs modulate enteroendocrine activity by acting as gatekeepers that limit the bioavailability of GLP-1. Although the function of IELs may prove advantageous when food is scarce, present-day overabundance of diets high in fat and sugar renders this metabolic checkpoint detrimental to health. Integrin β7-dependent Glp1r high natural gut intraepithelial T lymphocytes that reside in the small intestine modulate dietary metabolism in mice by restricting the bioavailability of GLP-1.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author Contributions. S.H. conceived project, designed, performed experiments, analyzed, interpreted data, and made figures; F.K. performed, analyzed, interpreted, and made figures; S.R., M.Nairz., A.A., C.M., D.S., A.M.F., C.C., J.E.M., C.V., W.C.P., Y.I., G.R.W., C.F-H. performed; R.W., P.L., C.F-H., D.J.D., M.N. provided intellectual input; R.W., C.F-H., D.J.D., M.N. provided materials; F.K.S. conceived, designed, interpreted, and wrote the manuscript. All edited the manuscript. The General Hospital Corporation has filed a U.S. patent application 62/771,668 with the U.S. Patent and Trademark office entitled “Targeting Intraepithelial Leukocytes for Treatment of Cardiometabolic Diseases”, which names F.K.S. and S.H. as inventors.
ISSN:0028-0836
1476-4687
DOI:10.1038/s41586-018-0849-9